ReShape Lifesciences Announces $2 Million Convertible Note Financing
SAN CLEMENTE, CA / ACCESSWIRE / March 29, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
SAN CLEMENTE, CA / ACCESSWIRE / March 29, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
TORONTO, ON / ACCESSWIRE / March 29, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) ("Intellipharmaceutics" or the...
LIVINGSTON, NJ / ACCESSWIRE / March 29, 2019 / Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized...
DENVER, CO / ACCESSWIRE / March 28, 2019 / Nexien BioPharma, Inc. ("Nexien" or the "Company") (OTCQB: NXEN), a next...
Venture capital group announces the launch of its new fund, Hypur Ventures II, that will invest up to $500MM into...
VANCOUVER, BC / ACCESSWIRE / March 28, 2019 / Cova is the point-of-sale (POS) solution of choice for nearly every...
DENVER, CO / ACCESSWIRE / March 28, 2019 / International Cannabrands Inc. (CSE: JUJU) (the "Company") is pleased to announce...
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 28, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
Company to Capitalize on $16.7 Billion Telehealth Market by Offering Patient Directed Testing Through an Independent Provider Network TORONTO, ON...
- Combination Synergistic Even in Cells That Have Developed Resistance to Bortezomib - Article Published in the March 12 Edition...
Recently announced interim HS-110 Phase 2 data demonstrating survival benefit in patients with ‘cold' tumors (CD8+ TILs < 10% at...
SAN FRANCISCO, CA / ACCESSWIRE / March 28, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a...
- EXCELLENCE IN SCIENCE, PARTNERED DRUG DISCOVERY & DEVELOPMENT, ACQUISITIONS, AND UNIQUE PLATFORM TECHNOLOGIES LEAD TO STRONG GROWTH MOMENTUM -...
KING OF PRUSSIA, PA / ACCESSWIRE / March 27, 2019 / Emergent Health Corp. (the "Company") purpose is to update...
TORONTO, ON / ACCESSWIRE / March 27, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces that it has signed...
Interim Results Demonstrated Preservation of Sperm Parameters After Six Months of Treatment with Nasally-Administered Natesto Testosterone Gel Natesto Spermatogenesis Study...
REDWOOD CITY, CA / ACCESSWIRE / March 27, 2019 / Avinger, Inc. (NASDAQ: AVGR), a leading developer of image-guided, catheter-based...
TORONTO, ON and HOUSTON, TX / ACCESSWIRE / March 27, 2019 / Medicenna Therapeutics Corp. (''Medicenna'' or the ''Company'') (TSX:...
SANYA, CHINA / ACCESSWIRE / March 26, 2019 / On the afternoon of March 24, the 2019 Hainan International Brand...
PLYMOUTH MEETING, Pa., March 26, 2019 /PRNewswire/ -- The Partnership for Health IT Patient Safety, a multi-stakeholder collaborative convened by...